Get Involved

How is Managed Access evolving across the industry?

Understand the landscape, help shape emerging good practice & move the industry forward.

Participate in the Global Managed Access Benchmark

Managed Access is becoming an increasingly strategic capability for pharmaceutical companies. Yet there is no shared industry benchmark for understanding how capabilities are structured, governed and delivered or how current approaches are evolving.

The Global Managed Access Benchmark (GMAB)
Is designed to help change that. Bringing together Managed Access leaders, it will build an evidence-led, industry-wide picture of currentpractice, emerging priorities and opportunities for improvement.

GMAB Will Explore

Strategy & Governance

How Managed Access is positioned, who owns decisions and oversight.

Strategy & Governance

How Managed Access is positioned, who owns decisions and oversight.

Operating Model

How programs are planned, resourced, managed and scaled globally.

Operating Model

How programs are planned, resourced, managed and scaled globally.

Cross-Functional Integration

How Medical, Regulatory, Supply, PV, Market Access and other functions work together, where responsibilities sit and where gaps occur.

Cross-Functional Integration

How Medical, Regulatory, Supply, PV, Market Access and other functions work together, where responsibilities sit and where gaps occur.

Technology & Data

How technology and data support delivery, visibility, evidence generationand decision-making.

Technology & Data

How technology and data support delivery, visibility, evidence generationand decision-making.

Measurement & Improvement

How performance, value and organizational capabilities are assessed.

Measurement & Improvement

How performance, value and organizational capabilities are assessed.

Patient Impact

How patients’ views inform program design, communication and delivery.

Patient Impact

How patients’ views inform program design, communication and delivery.

Strategy & Governance

How Managed Access is positioned, who owns decisions and oversight.

Operating Model

How programs are planned, resourced, managed and scaled globally.

Cross-Functional Integration

How Medical, Regulatory, Supply, PV, Market Access and other functions work together, where responsibilities sit and where gaps occur.

Technology & Data

How technology and data support delivery, visibility, evidence generation and decision-making.

Measurement & Improvement

How performance, value and organizational capabilities are assessed.

Patient Impact

How patients’ views inform program design, communication and delivery.

Your Involvement

There are two ways to take part in the Global Managed Access Benchmark

There are two ways to take part in the Global Managed Access Benchmark

Join the GMAB Advisory Panel

Join the GMAB Advisory Panel

A small group of senior Managed Access leaders helping to shape the benchmark.

A small group of senior Managed Access leaders helping to shape the benchmark.

Your commitment

Your commitment

Three 1-hour online discussions across the program

Three 1-hour online discussions across the program

Q4 2026: Help shape the research framework

Q4 2026: Help shape the research framework

Q1 2027: Review the proposed survey ahead of publication

Q1 2027: Review the proposed survey ahead of publication

Final discussion: Review anonymized findings and emerging conclusions

Final discussion: Review anonymized findings and emerging conclusions

Quantitative Survey Participants

Quantitative Survey Participants

Contribute to a confidential industry-wide study through a short survey.

Contribute to a confidential industry-wide study through a short survey.

Your commitment

Your commitment

One approximately 20-minute survey

One approximately 20-minute survey

No company-level information shared; findings reported in aggregate

No company-level information shared; findings reported in aggregate

Your data remains confidential

Your data remains confidential

No company-level information shared; findings reported in aggregate

No company-level information shared; findings reported in aggregate

Shared benefits of taking part

Confidential

Companies will not be ranked or identified; findings reported in aggregate

Confidential

Companies will not be ranked or identified; findings reported in aggregate

Insights

Support your internal discussions about governance, resources, and improvement

Insights

Support your internal discussions about governance, resources, and improvement

Report: Indvidual

Participants receive a confidential individual benchmarking report.

Report: Indvidual

Participants receive a confidential individual benchmarking report.

Report: Full

Advisory Panel members will receive a full copy of the anonymised report

Report: Full

Advisory Panel members will receive a full copy of the anonymised report

Exclusive access to the full final report and its insights will be reserved for study participants and Advisory Panel members.

Exclusive access to the full final report and its insights will be reserved for study participants and Advisory Panel members.

Help Create A Global View Of Managed Access

Complete the form and the GMAB team will be in touch
with further information. 

Complete the form and the GMAB team will be in touch with further information. 

Social media:

Take a personalized 15-minute tour

See Maprium in action

See Maprium in action

To request a demo, discuss your access challenges or learn more about Maprium, please use the secure form.